Advertisement
Screener

MARSHALL WACE, LLP Historic Quarter Change: Foreign Other Stocks, Sold Out

MARSHALL WACE, LLP historic quarter change: Foreign Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), over 21 quarters from 2013-06-30 to 2026-06-30, MARSHALL WACE, LLP opened 26 positions, added to 18, reduced 22 and sold out of 26.

  • Q1 2026: Stock ENGENE HOLDINGS; Country of operation —; Class COMMON STOCK; Shares before 343,928.
  • Q1 2026: Stock ONCOLYTICS BIO; Country of operation —; Class COMMON STOCK; Shares before 262,170.
  • Q4 2025: Stock URANIUM ROYALTY; Country of operation —; Class COMMON STOCK; Shares before 233,242.
  • Q3 2025: Stock AMERICAS GOLD AN; Country of operation —; Class COMMON STOCK; Shares before 208,601.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1318757), 21 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-13); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-13); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-13); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-13); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-10); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-12); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-11); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-06-30 to 2014-03-31, filed 2014-05-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026ENGENE HOLDINGS
CUSIP 29286M105
COMMON STOCK343,9280-343,928$3,105,670$0-$3,105,6702026-05-15
Q1 2026ONCOLYTICS BIO
CUSIP 682310875
COMMON STOCK262,1700-262,170$228,087$0-$228,0872026-05-15
Q4 2025URANIUM ROYALTY
CUSIP 91702V101
COMMON STOCK233,2420-233,242$1,002,940$0-$1,002,9402026-02-13
Q3 2025AMERICAS GOLD AN
CUSIP 03062D100
COMMON STOCK208,6010-208,601$168,966$0-$168,9662025-11-13
Q3 2024URANIUM ROYALTY
CUSIP 91702V101
COMMON STOCK83,9610-83,961$188,913$0-$188,9132024-11-14
Q2 2024FUSION PHARMACEU
CUSIP 36118A100
COMMON STOCK1,501,2830-1,501,283$32,007,354$0-$32,007,3542024-08-14
Q2 2024CRESCENT POINT
CUSIP 22576C101
COMMON STOCK1,442,4920-1,442,492$11,814,009$0-$11,814,0092024-08-14
Q2 2024TRICON RESIDENTI
CUSIP 89612W102
COMMON STOCK874,0110-874,011$9,745,223$0-$9,745,2232024-08-14
Q2 2024FORTUNA SILVER
CUSIP 349915108
COMMON STOCK211,3510-211,351$788,339$0-$788,3392024-08-14
Q2 2024JIN MEDICAL INTE
CUSIP G5140V112
COMMON STOCK191,0830-191,083$733,758$0-$733,7582024-08-14
Q3 2016CELATOR PHARMACE
CUSIP 15089R102
COMMON STOCK163,5900-163,590$4,938,000$0-$4,938,0002016-11-10
Q3 2016CALGON CARBON
CUSIP 129603106
COMMON STOCK154,3650-154,365$2,030,000$0-$2,030,0002016-11-10
Q3 2016CRESCENT POINT
CUSIP 22576C101
COMMON STOCK11,5660-11,566$183,000$0-$183,0002016-11-10
Q2 2016COCA-COLA ENTER
CUSIP 19122T109
COMMON STOCK368,7080-368,708$18,708,000$0-$18,708,0002016-08-12
Q1 2016CHUBB CORP
CUSIP 171232101
COMMON STOCK33,7240-33,724$4,473,000$0-$4,473,0002016-05-13
Q4 2015GLOBE SPECIALTY
CUSIP 37954N206
COMMON STOCK99,8190-99,819$1,211,000$0-$1,211,0002016-02-10
Q4 2015CALGON CARBON
CUSIP 129603106
COMMON STOCK69,2440-69,244$1,079,000$0-$1,079,0002016-02-10
Q4 2015SEAGATE TECHNOLO
CUSIP G7945M107
COMMON STOCK13,0960-13,096$587,000$0-$587,0002016-02-10
Q3 2015FMC TECHNOLOGIES
CUSIP 30249U101
COMMON STOCK188,4680-188,468$7,820,000$0-$7,820,0002015-11-12
Q2 2015WEATHERFORD INTE
CUSIP G48833100
COMMON STOCK220,9420-220,942$2,718,000$0-$2,718,0002015-08-14
Q2 2015GLOBE SPECIALTY
CUSIP 37954N206
COMMON STOCK24,9630-24,963$472,000$0-$472,0002015-08-14
Q4 2014MEDTRONIC INC
CUSIP 585055106
COMMON STOCK184,7510-184,751$11,445,000$0-$11,445,0002015-02-17
Q4 2014CHUBB CORP
CUSIP 171232101
COMMON STOCK5,3920-5,392$491,000$0-$491,0002015-02-17
Q4 2014WEATHERFORD INTE
CUSIP G48833100
COMMON STOCK14,3750-14,375$299,000$0-$299,0002015-02-17
Q3 2014FMC TECHNOLOGIES
CUSIP 30249U101
COMMON STOCK496,7770-496,777$30,338,000$0-$30,338,0002014-11-13
Q2 2014MEDTRONIC INC
CUSIP 585055106
COMMON STOCK82,9160-82,916$5,103,000$0-$5,103,0002014-08-14

Similar Firms

Firm NameCountry13F ValueHoldings
BAILLIE GIFFORD & COUnited Kingdom$97.893B906
VOYA INVESTMENT MANAGEMENT LLCUnited States$96.096B3,717
Boston PartnersUnited States$95.467B1,772
Allianz Asset Management GmbHGermany$95.382B3,758
Swedbank ABSweden$95.149B1,062
Pictet Asset Management Holding SASwitzerland$94.790B2,102
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEMUnited States$94.491B2,925
HighTower Advisors, LLCUnited States$94.219B3,796
Cetera Investment AdvisersUnited States$94.005B4,790
NORDEA INVESTMENT MANAGEMENT ABSweden$107.197B1,994